Pfizer asks docs to sign ‘Dear Insurer’ letters

Share this article:
Pfizer is enlisting doctors in its efforts to stave off generic erosion of Lipitor. The company has supplied doctors with a CD containing letters they can send to pharmacists and insurers petitioning them not to switch patients from Lipitor to a generic statin, according to USA Today. Public Citizen’s Sidney Wolf told the paper that the company was using doctors as “human shields” to protect its business. “I would say it’s unethical,” said Wolf. Merck’s Zocor (simvastatin) went off-patent last June. Lipitor, which loses exclusivity in 2010, is also struggling to preserve its market share against branded competitors Vytorin, from Merck/Schering-Plough, and Crestor, from AstraZeneca. Pfizer scored a Lipitor patent victory yesterday when The Supreme Court declined to intervene in Ranbaxy Laboratories appeal of a lower-court ruling upholding a Pfizer patent for Lipitor. Indian generics firm Ranbaxy was seeking to sell a generic version of Lipitor. The court's decision not to get involved appears to settle the matter in Pfizer's favor.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.